Try Fund Library Premium
For Free with a 30 day trial!
Global Equity
Click for more information on Fundata’s FundGrade.
|
NAVPS (01-28-2026) |
$14.18 |
|---|---|
| Change |
-$0.04
(-0.31%)
|
As at December 31, 2025
Inception Return (October 15, 2019): 11.55%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -3.77% | -0.46% | 2.02% | 11.21% | 11.21% | 16.43% | 16.16% | 10.28% | 11.29% | 10.69% | - | - | - | - |
| Benchmark | -0.91% | 1.63% | 11.64% | 16.60% | 16.60% | 21.61% | 20.86% | 11.44% | 12.65% | 12.73% | 13.93% | 11.84% | 12.32% | 11.59% |
| Category Average | -0.81% | 0.94% | 7.84% | 12.89% | 12.89% | 16.45% | 15.99% | 7.68% | 9.33% | 9.73% | 11.13% | 8.92% | 9.50% | 8.92% |
| Category Rank | 96 / 98 | 63 / 96 | 80 / 95 | 54 / 88 | 54 / 88 | 36 / 77 | 31 / 70 | 17 / 62 | 26 / 58 | 23 / 51 | - | - | - | - |
| Quartile Ranking | 4 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | - | - | - | - |
| Return % | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 6.95% | 1.03% | -2.12% | -2.42% | 3.30% | 2.25% | -1.99% | 3.19% | 1.34% | 0.84% | 2.57% | -3.77% |
| Benchmark | 3.94% | -1.04% | -4.18% | -2.97% | 5.37% | 3.64% | 2.87% | 1.95% | 4.75% | 2.78% | -0.21% | -0.91% |
13.89% (November 2020)
-9.04% (March 2020)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | 7.70% | 15.41% | -5.61% | 15.61% | 21.89% | 11.21% |
| Benchmark | 5.18% | 16.29% | -1.79% | 21.41% | 13.15% | 17.62% | -12.64% | 19.37% | 26.84% | 16.60% |
| Category Average | 3.86% | 14.23% | -5.38% | 19.94% | 11.73% | 16.21% | -13.86% | 15.08% | 20.13% | 12.89% |
| Quartile Ranking | - | - | - | - | 3 | 3 | 2 | 2 | 2 | 3 |
| Category Rank | - | - | - | - | 26/ 51 | 39/ 58 | 17/ 62 | 27/ 70 | 25/ 77 | 54/ 88 |
21.89% (2024)
-5.61% (2022)
AA&A Global Equity Value Fund Series O
Median
Other - Global Equity
| Standard Deviation | 10.01% | 11.51% | - |
|---|---|---|---|
| Beta | 0.74% | 0.76% | - |
| Alpha | 0.01% | 0.02% | - |
| Rsquared | 0.49% | 0.55% | - |
| Sharpe | 1.17% | 0.75% | - |
| Sortino | 2.43% | 1.23% | - |
| Treynor | 0.16% | 0.11% | - |
| Tax Efficiency | 80.52% | 78.17% | - |
| Volatility |
|
|
- |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 10.59% | 10.01% | 11.51% | - |
| Beta | 0.61% | 0.74% | 0.76% | - |
| Alpha | 0.01% | 0.01% | 0.02% | - |
| Rsquared | 0.39% | 0.49% | 0.55% | - |
| Sharpe | 0.81% | 1.17% | 0.75% | - |
| Sortino | 1.40% | 2.43% | 1.23% | - |
| Treynor | 0.14% | 0.16% | 0.11% | - |
| Tax Efficiency | 95.64% | 80.52% | 78.17% | - |
| Start Date | October 15, 2019 |
|---|---|
| Instrument Type | Exempt Product |
| Share Class | - |
| Legal Status | - |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | $137 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| ALD401 |
The investment objective of the Fund is to maximize capital appreciation and achieve a superior long-term rate of return from investing in the shares of publicly traded companies. The Fund aims to achieve higher returns than its benchmark while minimizing risk over a full market cycle.
-
| Portfolio Manager |
Allard, Allard & Associates Inc. |
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
- |
|---|---|
| Custodian |
Natcan Trust Company |
| Registrar |
- |
| Distributor |
- |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | No |
| PAC Initial Investment | - |
| PAC Subsequent | - |
| SWP Allowed | No |
| SWP Min Balance | - |
| SWP Min Withdrawal | - |
| MER | - |
|---|---|
| Management Fee | - |
| Load | No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | 0.00% |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
For Free with a 30 day trial!